NASDAQ · Medical - Care Facilities

AirSculpt Technologies, Inc. (AIRS) Stock

$1.20 -4.00% NASDAQ: AIRS Healthcare

Valuation

MetricValue
Price$1.20
Market Cap$86.51M
P/E Ratio-9.75
P/B Ratio1.20
P/S Ratio0.83
EPS (TTM)$-0.19
52-Week High$12.00
52-Week Low$1.18
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-12.52%
ROA-6.07%
ROCE-7.47%
Gross Margin-3.29%
Operating Margin-3.29%
Net Margin-7.79%
Debt/Equity0.67
Current Ratio0.54

Annual Financials (USD)

Metric20212022202320242025
Revenue$133.0M$169.0M$196.0M$180.0M$152.0M
Operating Profit$16.0M$-5.0M$9.0M$-2.0M$-5.0M
Net Profit$11.0M$-15.0M$-4.0M$-8.0M$-12.0M
EPS$-0.01$-0.26$-0.08$-0.14$-0.19
Op Margin11.8%-2.7%4.8%-1.0%-3.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$201.0M$201.0M$204.0M$210.0M$187.0M
Total Liabilities$117.0M$130.0M$120.0M$131.0M$100.0M
Cash$25.0M$10.0M$10.0M$8.0M$8.0M
Borrowings$101.0M$108.0M$100.0M$105.0M$84.0M

Latest News

AirSculpt Technologies Announces Participation in Upcoming Investor Conferences GlobeNewswire · May 27, 2026 AirSculpt Technologies Sees Sales Rebound, GLP-1 Tailwind for Body Contouring Growth MarketBeat · May 19, 2026 AirSculpt Technologies Q1 Earnings Call Highlights MarketBeat · May 8, 2026 AirSculpt Technologies Reports First Quarter Fiscal 2026 Results GlobeNewswire · May 8, 2026 AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results GlobeNewswire · May 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$27.0M$24.0M$24.0M$11.0M$3.0M
Investing Cash Flow$-14.0M$-26.0M$-20.0M$-28.0M$-5.0M
Financing Cash Flow$0$-2.0M$-1.0M$-2.0M$0
Net Cash Flow$15.0M$-16.0M$1.0M$-2.0M$0
Free Cash Flow$20.0M$12.0M$14.0M$-3.0M$1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.65
EV / EBITDA51.64
FCF Yield0.61%
Quick Ratio0.79
Interest Coverage-2.31
Return 1Y-27.60%
Return 3Y-45.06%
Return 5Y—

Ownership

Insiders Held43.06%
Institutions Held66.03%
Institutions Float Held115.98%
Institutional HolderSharesReport Date
Vesey Street Capital Partners, LLC30,324,1802026-03-31
Balyasny Asset Management LP2,326,6902026-03-31
FourWorld Capital Management, LLC987,7572026-03-31
Blackrock Inc.804,0792026-03-31
Wexford Capital LP670,5172026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMNAMN Healthcare Services Inc $48.01 +2.54% 13.57 $1.86B 0.00%
AQSTAquestive Therapeutics, Inc. $4.00 -3.15% -7.09 $502.05M 0.00%
CMPSCOMPASS Pathways plc $13.31 -0.60% -6.19 $1.28B 0.00%
CYHCommunity Health Systems, Inc. $2.92 +0.34% -1.20 $411.75M 0.00%
DRIODarioHealth Corp. $3.77 +10.56% 8.41 $36.94M 0.00%

About AirSculpt Technologies, Inc.

AirSculpt Technologies, Inc. is led by CEO Yogesh Jashnani, employs 389 people, headquartered in US, publicly traded since 2021.

AirSculpt Technologies, Inc. (AIRS) stock trades at $1.20 with a market capitalization of $86.51M. The stock is valued at a negative price-to-earnings (P/E) ratio of -9.75, reflecting a net loss over the last twelve months, price-to-book of 1.20, price-to-sales of 0.83. Over the past 52 weeks the stock has ranged between $1.18 and $12.00, and currently trades 90.0% below its 52-week high.

On profitability, AirSculpt Technologies, Inc. generates a return on equity (ROE) of -12.52% (negative, reflecting a net loss), return on capital employed of -7.47%, an operating margin of -3.29%, a net profit margin of -7.79%.

AirSculpt Technologies, Inc. by the numbers, 2019–2025

Between 2019 and 2025 AirSculpt Technologies, Inc. reported revenue of $41.0M rising to $152.0M, a change of +270.7% across 7 years. Compounded, revenue has grown 19.3% a year over five years, -3.5% over three, -15.6% over the last twelve months. Net profit fell to $-12.0M.

Operating margin went from 1.6% in 2019 to -3.2% in 2025, a fall of 4.8 percentage points. The most recent net margin is -7.79%. On a trailing twelve-month basis to Jun '26, revenue is $150.0M and net profit $-12.0M.

Borrowings rose from $45.0M to $84.0M, cash from operations was $3.0M in the latest year, positive in 7 of the last 7.

Return on equity has averaged -7.3% over five years, and was -13.6% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

AirSculpt Technologies, Inc. (AIRS) — frequently asked questions

What is AirSculpt Technologies, Inc. (AIRS) stock price today?

AirSculpt Technologies, Inc. (AIRS) is currently trading at $1.20, down 4% today.

What is AIRS P/E ratio?

AirSculpt Technologies, Inc.'s P/E ratio is -9.75. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is AIRS return on equity (ROE)?

AirSculpt Technologies, Inc.'s return on equity (ROE) is -12.52%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is AirSculpt Technologies, Inc.'s market cap?

AirSculpt Technologies, Inc. has a market capitalization of $86.51M.

Does AIRS pay a dividend?

AirSculpt Technologies, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does AIRS carry?

AirSculpt Technologies, Inc. has a debt-to-equity ratio of 0.67. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is AIRS's profit margin?

AirSculpt Technologies, Inc. reports a net profit margin of -7.79% — the share of revenue left after every cost, including tax and interest.

What sector is AIRS in?

AirSculpt Technologies, Inc. is classified under Healthcare, in the Medical - Care Facilities industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is AIRS listed on?

AirSculpt Technologies, Inc. trades on NASDAQ under the ticker AIRS.

What is AIRS's 52-week range?

Over the last year AirSculpt Technologies, Inc. has traded between $1.18 and $12.00.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens AIRS currently matches

On the figures above, AirSculpt Technologies, Inc. passes the filters for 2 of our ready-made screens, among them Penny Stocks, Micro Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Penny StocksMicro Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.